Page 3 - Flipbook
P. 3
Disclosures
• Institutional research funds: Bavarian Nordic; Bristol-Myers Squibb;
Clovis Oncology; Debiopharm; Immunomedics; Pfizer; Merck; QED
Therapeutics; GlaxoSmithKline; MiratiTherapeutics; Kure It Cancer
Research
• Consulting: AstraZeneca; DyaniaHealth; EMD Serono;
Immunomedics; Infinity Pharmaceuticals; Janssen; Merck;
MiratiTherapeutics; Genentech; Pfizer; Seattle Genetics